ENANTA PHARMACEUTICALS INC (ENTA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ENTA currently has 29M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 36.77% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 29.0M shares outstanding |
29M | 0 |
| Aug 13, 2025 |
10-Q filing | 21.4M shares outstanding |
21M | 0 |
| May 14, 2025 |
10-Q filing | 21.4M shares outstanding |
21M | 0 |
| Feb 12, 2025 |
10-Q filing | 21.2M shares outstanding |
21M | 0 |
| Nov 27, 2024 |
10-K filing | 21.2M shares outstanding |
21M | 0 |
| Aug 07, 2024 |
10-Q filing | 21.2M shares outstanding |
21M | 0 |
| May 08, 2024 |
10-Q filing | 21.2M shares outstanding |
21M | 0 |
| Feb 08, 2024 |
10-Q filing | 21.1M shares outstanding |
21M | 0 |
| Nov 22, 2023 |
S-3 filing: Enanta Pharmaceuticals, Inc. may offer and sell up to $150,000,000 in the aggregate of common stock, preferred stock, and debt securities from time to time, in one or more series or issuances. |
21M | 0 |
| Nov 22, 2023 |
10-K filing | 21.1M shares outstanding |
21M | 0 |
| Aug 08, 2023 |
10-Q filing | 21.1M shares outstanding |
21M | 0 |
| May 09, 2023 |
10-Q filing | 21.0M shares outstanding |
21M | 0 |
| Feb 08, 2023 |
10-Q filing | 20.8M shares outstanding |
21M | 0 |
| Nov 23, 2022 |
10-K filing | 20.8M shares outstanding |
21M | 0 |
| Aug 08, 2022 |
10-Q filing | 20.7M shares outstanding |
21M | 0 |
| May 09, 2022 |
10-Q filing | 20.6M shares outstanding |
21M | 0 |
| Feb 10, 2022 |
10-Q filing | 20.4M shares outstanding |
20M | 0 |
| Nov 24, 2021 |
10-K filing | 20.2M shares outstanding |
20M | 0 |
| Aug 09, 2021 |
10-Q filing | 20.2M shares outstanding |
20M | 0 |
| May 10, 2021 |
10-Q filing | 20.2M shares outstanding |
20M | 0 |
| Feb 09, 2021 |
10-Q filing | 20.1M shares outstanding |
20M | 0 |
| Nov 25, 2020 |
10-K filing | 19.9M shares outstanding |
20M | 0 |
| Aug 10, 2020 |
10-Q filing | 20.0M shares outstanding |
20M | 0 |
| May 11, 2020 |
10-Q filing | 19.9M shares outstanding |
20M | 0 |
| Feb 10, 2020 |
10-Q filing | 19.8M shares outstanding |
20M | 0 |